IL159266A0 - Crystalline forms of fexofenadine and processes for the preparation thereof - Google Patents

Crystalline forms of fexofenadine and processes for the preparation thereof

Info

Publication number
IL159266A0
IL159266A0 IL15926601A IL15926601A IL159266A0 IL 159266 A0 IL159266 A0 IL 159266A0 IL 15926601 A IL15926601 A IL 15926601A IL 15926601 A IL15926601 A IL 15926601A IL 159266 A0 IL159266 A0 IL 159266A0
Authority
IL
Israel
Prior art keywords
fexofenadine
processes
preparation
crystalline forms
crystalline
Prior art date
Application number
IL15926601A
Other languages
English (en)
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Publication of IL159266A0 publication Critical patent/IL159266A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL15926601A 2001-06-18 2001-07-31 Crystalline forms of fexofenadine and processes for the preparation thereof IL159266A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN484MA2001 2001-06-18
PCT/US2001/023994 WO2002102777A2 (fr) 2001-06-18 2001-07-31 Nouvelles formes cristallines d'acide 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-$g(a)-$g(a)- dimethylbenzene acetique et son chlorhydrate

Publications (1)

Publication Number Publication Date
IL159266A0 true IL159266A0 (en) 2004-06-01

Family

ID=34566868

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15926601A IL159266A0 (en) 2001-06-18 2001-07-31 Crystalline forms of fexofenadine and processes for the preparation thereof
IL159266A IL159266A (en) 2001-06-18 2003-12-09 Crystalline forms of fexofenadine and processes for the preparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159266A IL159266A (en) 2001-06-18 2003-12-09 Crystalline forms of fexofenadine and processes for the preparation thereof

Country Status (20)

Country Link
EP (2) EP2261209A1 (fr)
JP (2) JP2005507374A (fr)
KR (1) KR20040015734A (fr)
CN (1) CN100390145C (fr)
AU (1) AU2001278094B2 (fr)
BG (1) BG108435A (fr)
BR (1) BR0117054A (fr)
CA (2) CA2450858C (fr)
CO (1) CO5540340A2 (fr)
CZ (1) CZ20033358A3 (fr)
EE (1) EE200400010A (fr)
HU (1) HUP0401546A2 (fr)
IL (2) IL159266A0 (fr)
MX (1) MXPA03011728A (fr)
NZ (1) NZ530118A (fr)
PL (1) PL367632A1 (fr)
RU (1) RU2269516C2 (fr)
SK (1) SK15372003A3 (fr)
WO (1) WO2002102777A2 (fr)
ZA (1) ZA200309557B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366576A1 (en) * 2001-04-09 2005-02-07 Teva Pharmaceutical Industries Ltd. Polymorphs of fexofenadine hydrochloride
US20040044038A1 (en) 2002-06-10 2004-03-04 Barnaba Krochmal Polymorphic form XVI of fexofenadine hydrochloride
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
EP1628959A2 (fr) * 2004-04-26 2006-03-01 Teva Pharmaceutical Industries Ltd Formes cristallines d'hydrochlorure de fexofenadine, et procedes pour les preparer
ITMI20041143A1 (it) * 2004-06-08 2004-09-08 Dipharma Spa Polimorfi di fexofenadina e procedimento per la loro preparazione
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
JP2008514641A (ja) * 2004-09-28 2008-05-08 テバ ファーマシューティカル インダストリーズ リミティド 結晶形フェキソフェナジン、およびその調製方法
WO2007007347A1 (fr) * 2005-07-07 2007-01-18 Wockhardt Limited Procédé industriel de préparation du chlorhydrate de fexofénadine avec un minimum de produits secondaires
EP2105134A1 (fr) 2008-03-24 2009-09-30 Ranbaxy Laboratories Limited Hydrochlorure de fexofenadine amorphe stable
CN104072402B (zh) * 2014-07-16 2016-08-17 昆山龙灯瑞迪制药有限公司 一种新结晶形式的盐酸非索非那定化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
JPH10500134A (ja) * 1994-05-18 1998-01-06 ヘキスト・マリオン・ルセル・インコーポレイテツド 抗ヒスタミン性ピペリジン誘導体の無水および水和形態、それらの多形態および擬似形態の製造方法
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
IN191492B (fr) 1999-05-25 2003-12-06 Ranbaxy Lab Ltd
GB0018691D0 (en) * 2000-07-28 2000-09-20 Rolabo Sl Process

Also Published As

Publication number Publication date
CZ20033358A3 (en) 2004-04-14
WO2002102777A8 (fr) 2003-10-30
CN1518540A (zh) 2004-08-04
BR0117054A (pt) 2004-07-27
CA2450858C (fr) 2009-04-07
JP2008094848A (ja) 2008-04-24
SK15372003A3 (sk) 2004-08-03
EP2261209A1 (fr) 2010-12-15
AU2001278094B2 (en) 2006-01-12
RU2004101045A (ru) 2005-06-27
RU2269516C2 (ru) 2006-02-10
CA2450858A1 (fr) 2002-12-27
WO2002102777A3 (fr) 2003-02-27
WO2002102777A2 (fr) 2002-12-27
MXPA03011728A (es) 2004-07-08
IL159266A (en) 2010-11-30
CN100390145C (zh) 2008-05-28
PL367632A1 (en) 2005-03-07
BG108435A (en) 2004-12-30
NZ530118A (en) 2007-05-31
EE200400010A (et) 2004-02-16
EP1399422A2 (fr) 2004-03-24
JP2005507374A (ja) 2005-03-17
KR20040015734A (ko) 2004-02-19
CA2646802A1 (fr) 2002-12-27
HUP0401546A2 (hu) 2004-12-28
ZA200309557B (en) 2004-09-14
CO5540340A2 (es) 2005-07-29

Similar Documents

Publication Publication Date Title
EP1425279A4 (fr) Procede de preparation de tetrahydrobenzothiepines cristallines
TW479494U (en) Structure of pillow
GB0112699D0 (en) Process for the preparation of prostglandins and analogues thereof
IL159626A0 (en) Crystalline forms of atorvastatin calcium and processes for the preparation thereof
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
IL159266A (en) Crystalline forms of fexofenadine and processes for the preparation thereof
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
GB0115581D0 (en) Method of mass spectometry
AU2003260078A8 (en) Crystalline and amorphous forms of (s) -repaglinide and the processes for preparation thereof
AU2002337843A8 (en) Processes for the preparation of substituted isoxazoles and 2-isoxazolines
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
IL162770A0 (en) Process for the preparation methylsteroids of 7
AU2003298725A8 (en) Preparation of metallotexaphyrins
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
IL164788A0 (en) Process for the preparation of 3-isochromanone
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
TW493722U (en) Improved structure of lampwick
IL165356A0 (en) Preparation of 4-haloalkylkylnicotinamides
HU0104370D0 (en) Honeyed schnaps of oerseg
HUP0401165A3 (en) Process for the preparation of 5-formylphtalide
GB0113667D0 (en) Process for the preparation of endo-5-norbornene-2-ol
HRP20010190B1 (en) Process for the preparation of alpha-arbutine
GB0105878D0 (en) Novel process for the preparation of pyrazoloprimidinones
TW493490U (en) Improved structure of wrench